Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Radiation Fibrosis Syndrome 2 Pancreatic Neoplasms 2 Pancreatic Adenocarcinoma 2 Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Ductal Adenocarcinoma 1 Osteosarcoma 1 Neuroma, Acoustic 1 Inflammation 1 Fibrosis 1 Fallopian Tube Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Hepatocellular 1 Camurati-Engelmann Syndrome 1

Interventions

Cyclophosphamide 13 Specimen Handling 9 cabozantinib 8 X-Rays 8 Magnetic Resonance Spectroscopy 8 fludarabine 7 Phantoms, Imaging 7 Biopsy 7 Temozolomide 6 Methotrexate 6 Zoledronic Acid 5 Gemcitabine 5 Doxorubicin 5 regorafenib 4 pembrolizumab 4 Vincristine 4 Nuclear Medicine Department, Hospital 4 Nivolumab 4 Ifosfamide 4 Cisplatin 4 olaparib 3 irinotecan sucrosofate 3 fludarabine phosphate 3 dinutuximab 3 Surveys and Questionnaires 3 Irinotecan 3 Etoposide 3 ulixertinib 2 tipifarnib 2 tazemetostat 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Osteosarcoma × Losartan × 1 year × Clear all

NCT03900793 2026-02-03

Losartan + Sunitinib in Treatment of Osteosarcoma

University of Colorado, Denver

Phase 1 Recruiting

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡